Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1988 1
1995 1
1999 1
2000 6
2001 1
2002 1
2003 4
2004 10
2005 11
2006 16
2007 22
2008 27
2009 42
2010 41
2011 71
2012 67
2013 82
2014 81
2015 101
2016 99
2017 155
2018 150
2019 160
2020 204
2021 294
2022 284
2023 308
2024 151

Text availability

Article attribute

Article type

Publication date

Search Results

2,069 results

Results by year

Filters applied: . Clear all
Page 1
Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing - a randomised controlled trial.
Olsen MT, Klarskov CK, Pedersen-Bjergaard U, Hansen KB, Kristensen PL. Olsen MT, et al. BMC Endocr Disord. 2024 May 6;24(1):60. doi: 10.1186/s12902-024-01595-4. BMC Endocr Disord. 2024. PMID: 38711112 Free PMC article. Clinical Trial.
The DIATEC trial investigates the effects of an in-hospital diabetes team and operational insulin titration algorithms based on either continuous glucose monitoring (CGM) data or standard point-of-care (POC) glucose testing. ...We recruit non-critically ill h …
The DIATEC trial investigates the effects of an in-hospital diabetes team and operational insulin titration algorithms based on either co …
Budget impact analysis of continuous glucose monitoring in individuals with type 2 diabetes on insulin treatment in England.
Alsaif M, Farhat A, Blumer Z, Barham L. Alsaif M, et al. Health Econ Rev. 2024 May 6;14(1):32. doi: 10.1186/s13561-024-00505-7. Health Econ Rev. 2024. PMID: 38709338 Free PMC article.
INTRODUCTION: In 2022, updated guidance from NICE expanded the options for self-monitoring of blood glucose for patients with type 2 diabetes (T2DM), to include continuous glucose monitoring (CGM). ...
INTRODUCTION: In 2022, updated guidance from NICE expanded the options for self-monitoring of blood glucose for patients with type …
Quality of Life and Its Association With Time in Range Among People With Type 2 Diabetes Mellitus Following Different Dietary Interventions: A Crossover Clinical Trial.
Deshmane AR, Muley A. Deshmane AR, et al. Cureus. 2024 Apr 4;16(4):e57624. doi: 10.7759/cureus.57624. eCollection 2024 Apr. Cureus. 2024. PMID: 38707009 Free PMC article.
Numerous studies have examined QoL in India; however, data on QoL following different dietary interventions are lacking. Similarly, the use of technology such as continuous glucose monitoring (CGM) for diabetes care has independently demonstrated improvements …
Numerous studies have examined QoL in India; however, data on QoL following different dietary interventions are lacking. Similarly, the use …
The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial.
Ambery P, Zajac G, Almquist J, Prothon S, Astbury C, Brown MN, Nemes S, Nsabimana J, Edman K, Öberg L, Lepistö M, Edenro G, Dillmann I, Mitra S, Belfield G, Keen C, Heise T. Ambery P, et al. Br J Clin Pharmacol. 2024 May 1. doi: 10.1111/bcp.16082. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38690606
This study investigated the mechanisms driving differential effects on glucose control for AZD9567, an oral nonsteroidal selective glucocorticoid receptor modulator vs. prednisolone in 46 patients with type 2 diabetes mellitus. METHODS: In this randomized, double-bl …
This study investigated the mechanisms driving differential effects on glucose control for AZD9567, an oral nonsteroidal selective glucocort …
Optimizing type 2 diabetes management: AI-enhanced time series analysis of continuous glucose monitoring data for personalized dietary intervention.
Anjum M, Saher R, Saeed MN. Anjum M, et al. PeerJ Comput Sci. 2024 Apr 22;10:e1971. doi: 10.7717/peerj-cs.1971. eCollection 2024. PeerJ Comput Sci. 2024. PMID: 38686006 Free PMC article.
The worse effects of Type 2 diabetes mellitus are precisely associated with the poor lifestyle adopted by patients. ...This study was done to help T2DM patients improve their health by developing a favorable lifestyle under an AI-assisted Continuous glucos …
The worse effects of Type 2 diabetes mellitus are precisely associated with the poor lifestyle adopted by patients. ...This st …
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies.
Morita M, Sada K, Hidaka S, Ogawa M, Shibata H. Morita M, et al. J Diabetes Investig. 2024 Apr 29. doi: 10.1111/jdi.14211. Online ahead of print. J Diabetes Investig. 2024. PMID: 38685597 Free article.
AIMS/INTRODUCTION: Although several studies have shown the association between continuous glucose monitoring (CGM)-derived glycemic variability (GV) and diabetic peripheral neuropathy, no studies have focused on outpatients or used NC-stat/DPNCheck, a new poi …
AIMS/INTRODUCTION: Although several studies have shown the association between continuous glucose monitoring (CGM)-deri …
Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
Reed J, Dong T, Eaton E, Friswold J, Porges J, Al-Kindi SG, Rajagopalan S, Neeland IJ. Reed J, et al. Diabetes Obes Metab. 2024 Apr 28. doi: 10.1111/dom.15608. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38680050
AIM: To evaluate the impact of the Dexcom G6 continuous glucose monitoring (CGM) device on glycaemic control and cardiometabolic risk in patients with type 2 diabetes mellitus (T2DM) at high cardiovascular risk who are not on insulin therapy. .. …
AIM: To evaluate the impact of the Dexcom G6 continuous glucose monitoring (CGM) device on glycaemic control and cardio …
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.
Bergenstal RM, Philis-Tsimikas A, Wysham C, Carr MC, Bue-Valleskey JM, Botros FT, Blevins T, Rosenstock J. Bergenstal RM, et al. Diabetes Obes Metab. 2024 Apr 28. doi: 10.1111/dom.15604. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38679838 Review.
MATERIALS AND METHODS: The five trials included insulin-naive adults (QWINT-1 and -2) with type 2 diabetes (T2D), adults with T2D previously treated with basal insulin (QWINT-3 and -4), and QWINT-5 in adults with type 1 diabetes. ...The key secondary objectives incl …
MATERIALS AND METHODS: The five trials included insulin-naive adults (QWINT-1 and -2) with type 2 diabetes (T2D), adults with …
Technology for the Management of Type 1 Diabetes Mellitus in Saudi Arabia and MENA Region: A Systematic Review.
Al Hayek A, Al Dawish MA. Al Hayek A, et al. Curr Diabetes Rev. 2024 Apr 26. doi: 10.2174/0115733998295755240416060913. Online ahead of print. Curr Diabetes Rev. 2024. PMID: 38676508
Therefore, 25 articles involving a total of 3088 participants were enrolled in the study. It was shown that a continuous glucose monitoring system and continuous subcutaneous insulin infusion improved the glycemic control and the QoL of T1DM patients. CONCLUS …
Therefore, 25 articles involving a total of 3088 participants were enrolled in the study. It was shown that a continuous glucose …
Physical Activity Detection for Diabetes Mellitus Patients Using Recurrent Neural Networks.
Dénes-Fazakas L, Simon B, Hartvég Á, Kovács L, Dulf ÉH, Szilágyi L, Eigner G. Dénes-Fazakas L, et al. Sensors (Basel). 2024 Apr 10;24(8):2412. doi: 10.3390/s24082412. Sensors (Basel). 2024. PMID: 38676028 Free PMC article.
Diabetes mellitus (DM) is a persistent metabolic disorder associated with the hormone insulin. The two main types of DM are type 1 (T1DM) and type 2 (T2DM). Physical activity plays a crucial role in the therapy of diabetes, benefiting both types of patients. The det …
Diabetes mellitus (DM) is a persistent metabolic disorder associated with the hormone insulin. The two main types of DM are type 1 (T1DM) an …
2,069 results